Log in

ProShares Ultra Nasdaq Biotechnology Stock Forecast, Price & News

+1.75 (+2.55 %)
(As of 10/22/2020 12:00 AM ET)
Today's Range
Now: $70.25
50-Day Range
MA: $69.83
52-Week Range
Now: $70.25
Volume256,900 shs
Average Volume211,121 shs
Market Capitalization$196.70 million
P/E RatioN/A
Dividend Yield0.00%

Geographic Exposure of BIB

Currency Exposure of BIB

Sector Exposure of BIB

Industry Exposure of BIB

Basic Details

Issuer ProShares
Fund NameProShares Ultra Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$220.71 million
Average Daily Volume$94,330.50

ETF Expenses

Management Fee0.75%
Other Expenses0.29%
Total Expenses1.04%
Fee Waiver-0.09%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Lead Market MakerVirtu Financial
+1.75 (+2.55 %)
(As of 10/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIB News and Ratings via Email

Sign-up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

ProShares Ultra Nasdaq Biotechnology (NYSEARCA:BIB) Frequently Asked Questions

How has ProShares Ultra Nasdaq Biotechnology's stock price been impacted by COVID-19 (Coronavirus)?

ProShares Ultra Nasdaq Biotechnology's stock was trading at $47.23 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BIB shares have increased by 48.7% and is now trading at $70.25.
View which stocks have been most impacted by COVID-19

What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include Alibaba Group (BABA), TENCENT HOLDING/ADR (TCEHY), Biogen (BIIB), ACADIA Pharmaceuticals (ACAD), Gilead Sciences (GILD), KraneShares MSCI All China Health Care Index ETF (KURE), The Meet Group (MEET), SEA (SE), Crispr Therapeutics (CRSP) and Cisco Systems (CSCO).

What is ProShares Ultra Nasdaq Biotechnology's stock symbol?

ProShares Ultra Nasdaq Biotechnology trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BIB."

How do I buy shares of ProShares Ultra Nasdaq Biotechnology?

Shares of BIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

One share of BIB stock can currently be purchased for approximately $70.25.

How big of a company is ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology has a market capitalization of $196.70 million.

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.